Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. (Q44604150)
Jump to navigation
Jump to search
scientific article published in October 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. |
scientific article published in October 2003 |
Statements
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics (English)
Peter S Dragovich
Thomas J Prins
Ru Zhou
Theodore O Johnson
Ye Hua
Hiep T Luu
Sylvie K Sakata
Edward L Brown
Fausto C Maldonado
Tove Tuntland
Caroline A Lee
Shella A Fuhrman
Leora S Zalman
Amy K Patick
David A Matthews
Ellen Y Wu
Ming Guo
Bennett C Borer
Naresh K Nayyar
Terence Moran
Lijian Chen
Paul A Rejto
Mark C Guzman
Elena Z Dovalsantos
Steven Lee
Kevin McGee
Michael Mohajeri
Andreas Liese
Junhua Tao
Maha B Kosa
Bo Liu
Minerva R Batugo
Jean-Paul R Gleeson
Zhen Ping Wu
Jia Liu
Rose Ann Ferre